https://doi.org/10.3389/fmicb.2018.00948
R
Raminderjit Kaur
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
25
Papers
947
Citations
10
h-index
10
i10-index
Raminderjit Kaur is an academic researcher from Cleveland Clinic Lerner College of Medicine. The author has contributed to research in topics: Bone Tissue Engineering Materials & Psoriasis: Treatment and Pathogenesis & Spondyloarthritis Studies and Treatments. The author has an h-index of 10, co-authored 22 publications.
ORCID: 0000-0001-9469-0986Papers by this author
worksProteinaceous Secretory Metabolites of Probiotic Human Commensal Enterococcus hirae 20c, E. faecium 12a and L12b as Antiproliferative Agents Against Cancer Cell Lines
2018 · Frontiers in Microbiology · 37 citations
TNFR2 Depletion Reduces Psoriatic Inflammation in Mice by Downregulating Specific Dendritic Cell Populations in Lymph Nodes and Inhibiting IL-23/IL-17 Pathways
2022 · Journal of Investigative Dermatology · 11 citations
https://doi.org/10.1016/j.jid.2021.12.036
Targeting dendritic cell-specific TNFR2 improves skin and joint inflammation in a murine model of psoriatic arthritis
2025 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-025-15175-6
Targeting dendritic cell-specific TNFR2 improves skin and joint inflammation by inhibiting IL-12/ IFN-γ pathways in a mouse model of psoriatic arthritis
2024 · bioRxiv (Cold Spring Harbor Laboratory) · 1 citations
https://doi.org/10.1101/2024.06.20.598545
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat